Global AIDS group calls on Boehringer ingelheim to increase access to drugs
This article was originally published in Scrip
Executive Summary
The AIDS Healthcare Foundation (AHF) is accusing Boehringer Ingelheim of steadfastly refusing to offer increased access to its lifesaving AIDS drugs or to respond in any way to repeated requests to do its part in helping alleviate a current crisis facing low-income Americans. Tom Myers, AHF's chief of public affairs and general counsel, says that many AIDS drug makers are making an effort to make access easier by expediting their own patient assistance programmes, although this hasn't fully happened yet. But the advocacy group claims that Boehringer is an "outlier" even among this group.